Hypolipidimic and antioxidant activities of virgin olive oil and its fractions in 2,4-diclorophenoxyacetic acid-treated rats

Nutrition. 2012 Jan;28(1):81-91. doi: 10.1016/j.nut.2011.02.009. Epub 2011 Jul 23.

Abstract

Objective: We examined the effects of extra virgin olive oil (EVOO) and its hydrophilic and lipophilic fractions on serum lipids, oxidative stress, and morphologic and functional liver damages induced by 2,4-diclorophenoxyacetic acid (2,4-D).

Methods: Male Wistar rats were divided randomly into eight groups: control; 2,4-D at a dose of 5 mg/kg of body weight (2,4-D); 2,4-D plus EVOO (2,4-D/EVOO); 2,4-D plus the hydrophilic fraction (2,4-D/OOHF); 2,4-D plus the lipophilic fraction (2,4-D/OOLF); only EVOO (EVOO); only the hydrophilic fraction (OOHF); and only the lipophilic fraction (OOLF). These components were administered daily by gavage for 4 wk.

Results: A hepatic architecture aberration, increased activities of aspartate and alanine aminotransferase enzymes, total and low-density lipoprotein cholesterol, and malondialdehyde (MDA) level, and a decreased antioxidant defense system were observed in the 2,4-D group. The administration of EVOO restored the damage caused by 2,4-D by a significant decrease of plasma total and low-density lipoprotein levels and a moderate increase of high-density lipoprotein cholesterol. The 2,4-D/OOHF group exhibited a pronounced enhancement of the antioxidant defense system by an increase of superoxide dismutase, catalase, and glutathione peroxidase levels and a decrease of plasma and liver MDA levels. However, less improvement in the liver histoarchitecture and antioxidant status was observed in rats supplemented with OOLF diet, despite its richness in α-tocopherol.

Conclusion: Extra virgin olive oil may be a potential functional food source of antioxidants than can decrease the frequency of cardiovascular diseases and liver damage.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,4-Dichlorophenoxyacetic Acid / toxicity*
  • Animals
  • Antioxidants / chemistry
  • Antioxidants / therapeutic use*
  • Atherosclerosis / etiology
  • Atherosclerosis / prevention & control
  • Chemical Fractionation
  • Chemical and Drug Induced Liver Injury / blood
  • Chemical and Drug Induced Liver Injury / pathology
  • Chemical and Drug Induced Liver Injury / physiopathology
  • Chemical and Drug Induced Liver Injury / prevention & control*
  • Food Handling
  • Hepatic Insufficiency / etiology
  • Hepatic Insufficiency / prevention & control
  • Hydrophobic and Hydrophilic Interactions
  • Hyperlipoproteinemias / etiology
  • Hyperlipoproteinemias / prevention & control
  • Hypolipidemic Agents / chemistry
  • Hypolipidemic Agents / therapeutic use*
  • Lipid Peroxidation / drug effects
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology*
  • Liver / physiopathology
  • Male
  • Olive Oil
  • Oxidative Stress
  • Oxidoreductases / blood
  • Oxidoreductases / metabolism
  • Pesticides / toxicity*
  • Plant Oils / chemistry
  • Plant Oils / therapeutic use*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Risk Factors

Substances

  • Antioxidants
  • Hypolipidemic Agents
  • Olive Oil
  • Pesticides
  • Plant Oils
  • 2,4-Dichlorophenoxyacetic Acid
  • Oxidoreductases